Shilpa Medicare's NorUDCA Gains Notable Approval as First Global NAFLD Therapy Shilpa Medicare's NorUDCA is the world's first approved therapy for Non-Alcoholic Fatty Liver Disease, offering hope to millions affected globally.

Shilpa Medicare's NorUDCA Gains Notable Approval as First Global NAFLD Therapy #India #Shilpa_Medicare #Raichur #NorUDCA #NAFLD

Shilpa Medicare's NorUDCA Achieves Milestone as First Approved NAFLD Therapy Shilpa Medicare has made history with NorUDCA, the world's first approved therapy for NAFLD, offering hope for over 1 billion patients globally.

Shilpa Medicare's NorUDCA Achieves Milestone as First Approved NAFLD Therapy #India #Shilpa_Medicare #Raichur #NorUDCA #NAFLD

Shilpa Medicare's NorUDCA Marks a Revolutionary Approval for NAFLD Treatment Shilpa Medicare's groundbreaking therapy NorUDCA is the first globally approved treatment for NAFLD, promising hope for over a billion affected individuals.

Shilpa Medicare's NorUDCA Marks a Revolutionary Approval for NAFLD Treatment #India #Shilpa_Medicare #Raichur #NorUDCA #NAFLD

Shilpa Medicare Makes Groundbreaking Move with NorUDCA, First NAFLD Therapy Approved Worldwide Shilpa Medicare's NorUDCA is the first-ever therapy approved globally for Non-Alcoholic Fatty Liver Disease, offering hope to millions suffering worldwide.

Shilpa Medicare Makes Groundbreaking Move with NorUDCA, First NAFLD Therapy Approved Worldwide #India #Shilpa_Medicare #Raichur #NorUDCA #NAFLD